Trait: major depressive disorder

Trait Information
Identifier MONDO_0002009
Description An episode of depression lasting two or more weeks without an intervening episode of mania. [NCIT: P378]
Trait category
Neurological disorder
Synonyms 10 synonyms
  • MDD
  • major depression
  • major depressive disorder
  • major depressive disorder and accelerated response to antidepressant drug treatment
  • major depressive disorder, response to citalopram therapy in
  • recurrent major depression
  • seasonal affective disorder, susceptibility to
  • single major depressive episode
  • unipolar depression
  • unipolar depression, susceptibility to
Mapped terms 14 mapped terms
  • DOID:1470
  • DOID:2848
  • EFO:0003761
  • ICD9:296.2
  • ICD9:296.20
  • ICD9:296.3
  • ICD9:296.30
  • MESH:D003865
  • MFOMD:0000143
  • NCIT:C34796
  • NCIT:C35094
  • OMIM:608516
  • SCTID:300706003
  • SCTID:370143000

Associated Polygenic Score(s)

Filter PGS by Participant Ancestry
Individuals included in:
G - Source of Variant Associations (GWAS)
D - Score Development/Training
E - PGS Evaluation
List of ancestries includes:
Display options:
Ancestry legend
Multi-ancestry (including European)
Multi-ancestry (excluding European)
African
East Asian
South Asian
Additional Asian Ancestries
European
Greater Middle Eastern
Hispanic or Latin American
Additional Diverse Ancestries
Not Reported
Polygenic Score ID & Name PGS Publication ID (PGP) Reported Trait Mapped Trait(s) (Ontology) Number of Variants Ancestry distribution Scoring File (FTP Link)
PGS000138
(LifetimeMDD)
PGP000068 |
Cai N et al. Nat Genet (2020)
Lifetime Major Depressive Disorder major depressive disorder 22,274
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000138/ScoringFiles/PGS000138.txt.gz
PGS000139
(MDDRecur)
PGP000068 |
Cai N et al. Nat Genet (2020)
Lifetime Major Depressive Disorder (with recurrence) recurrent,
major depressive disorder
21,980
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000139/ScoringFiles/PGS000139.txt.gz
PGS000145
(ICD10Dep)
PGP000068 |
Cai N et al. Nat Genet (2020)
Depression (ICD-10 defined) major depressive disorder 21,510
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000145/ScoringFiles/PGS000145.txt.gz
PGS000193
(MDD_0.001_Coleman_2020)
PGS000080 |
Coleman JRI et al. Mol Psychiatry (2020)
Major depression major depressive disorder 1,138
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000193/ScoringFiles/PGS000193.txt.gz
PGS000907
(PRS_MDD)
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Major depressive disorder major depressive disorder 1,773,528
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000907/ScoringFiles/PGS000907.txt.gz
PGS002789
(MDD_SDPR)
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Major depressive disorder major depressive disorder 943,784
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002789/ScoringFiles/PGS002789.txt.gz

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM)
Evaluated Score PGS Sample Set ID
(PSS)
Performance Source Trait PGS Effect Sizes
(per SD change)
Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM000430 PGS000138
(LifetimeMDD)
PSS000250|
European Ancestry|
36,709 individuals
PGP000068 |
Cai N et al. Nat Genet (2020)
Reported Trait: Major Depressive Disorder status AUROC: 0.5611 : 0.01817 Cohort
PPM000431 PGS000139
(MDDRecur)
PSS000250|
European Ancestry|
36,709 individuals
PGP000068 |
Cai N et al. Nat Genet (2020)
Reported Trait: Major Depressive Disorder status AUROC: 0.54874 : 0.01097 Cohort
PPM000437 PGS000145
(ICD10Dep)
PSS000250|
European Ancestry|
36,709 individuals
PGP000068 |
Cai N et al. Nat Genet (2020)
Reported Trait: Major Depressive Disorder status AUROC: 0.5251 : 0.0032 Cohort
PPM000564 PGS000193
(MDD_0.001_Coleman_2020)
PSS000294|
European Ancestry|
92,957 individuals
PGS000080 |
Coleman JRI et al. Mol Psychiatry (2020)
Reported Trait: Major depressive disorder OR: 1.179 : 0.01485
Nagelkerke pseudo-R2 (increase when adding PRS to null model of covariates): 0.00785
batch, centre, genomic prinicipal components (x6)
PPM002681 PGS000907
(PRS_MDD)
PSS001279|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Headaches in Escitalopram takers OR: 1.0 [0.92, 1.1] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002682 PGS000907
(PRS_MDD)
PSS001284|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Headaches in Venlafaxine takers OR: 1.05 [0.96, 1.15] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002684 PGS000907
(PRS_MDD)
PSS001281|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Headaches in Mirtazapine takers OR: 1.05 [0.91, 1.22] Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20
PPM002685 PGS000907
(PRS_MDD)
PSS001277|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Headaches in Desvenlafaxine takers OR: 1.01 [0.91, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002686 PGS000907
(PRS_MDD)
PSS001276|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Headaches in Citalopram takers OR: 1.02 [0.9, 1.16] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002687 PGS000907
(PRS_MDD)
PSS001280|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Headaches in Fluoxetine takers OR: 1.06 [0.96, 1.17] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002688 PGS000907
(PRS_MDD)
PSS001278|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Headaches in Duloxetine takers OR: 1.06 [0.95, 1.2] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002689 PGS000907
(PRS_MDD)
PSS001282|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Headaches in Paroxetine takers OR: 1.08 [0.92, 1.26] Variance explained (Nagelkerke's R2*100): 0.11 sex, age at study enrollment, genetic PCs 1-20
PPM002690 PGS000907
(PRS_MDD)
PSS001243|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dizziness in Sertraline takers OR: 1.06 [0.98, 1.14] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002691 PGS000907
(PRS_MDD)
PSS001239|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dizziness in Escitalopram takers OR: 1.06 [0.98, 1.15] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002692 PGS000907
(PRS_MDD)
PSS001244|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dizziness in Venlafaxine takers OR: 1.01 [0.93, 1.09] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002693 PGS000907
(PRS_MDD)
PSS001235|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dizziness in Amitriptyline takers OR: 0.96 [0.83, 1.1] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002694 PGS000907
(PRS_MDD)
PSS001241|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dizziness in Mirtazapine takers OR: 1.07 [0.93, 1.23] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002695 PGS000907
(PRS_MDD)
PSS001237|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dizziness in Desvenlafaxine takers OR: 0.97 [0.87, 1.07] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002696 PGS000907
(PRS_MDD)
PSS001236|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dizziness in Citalopram takers OR: 0.99 [0.87, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002697 PGS000907
(PRS_MDD)
PSS001240|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dizziness in Fluoxetine takers OR: 1.16 [1.04, 1.29] Variance explained (Nagelkerke's R2*100): 0.41 sex, age at study enrollment, genetic PCs 1-20
PPM002698 PGS000907
(PRS_MDD)
PSS001238|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dizziness in Duloxetine takers OR: 0.98 [0.88, 1.1] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002699 PGS000907
(PRS_MDD)
PSS001242|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dizziness in Paroxetine takers OR: 1.08 [0.93, 1.24] Variance explained (Nagelkerke's R2*100): 0.12 sex, age at study enrollment, genetic PCs 1-20
PPM002700 PGS000907
(PRS_MDD)
PSS001373|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Shakes in Sertraline takers OR: 1.03 [0.94, 1.12] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002701 PGS000907
(PRS_MDD)
PSS001369|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Shakes in Escitalopram takers OR: 1.01 [0.9, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002702 PGS000907
(PRS_MDD)
PSS001374|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Shakes in Venlafaxine takers OR: 1.1 [1.0, 1.22] Variance explained (Nagelkerke's R2*100): 0.18 sex, age at study enrollment, genetic PCs 1-20
PPM002703 PGS000907
(PRS_MDD)
PSS001365|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Shakes in Amitriptyline takers OR: 0.99 [0.81, 1.2] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002704 PGS000907
(PRS_MDD)
PSS001371|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Shakes in Mirtazapine takers OR: 1.03 [0.86, 1.24] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002705 PGS000907
(PRS_MDD)
PSS001367|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Shakes in Desvenlafaxine takers OR: 1.04 [0.92, 1.18] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002707 PGS000907
(PRS_MDD)
PSS001370|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Shakes in Fluoxetine takers OR: 1.06 [0.95, 1.19] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002708 PGS000907
(PRS_MDD)
PSS001368|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Shakes in Duloxetine takers OR: 0.9 [0.79, 1.04] Variance explained (Nagelkerke's R2*100): 0.21 sex, age at study enrollment, genetic PCs 1-20
PPM002709 PGS000907
(PRS_MDD)
PSS001372|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Shakes in Paroxetine takers OR: 1.19 [1.0, 1.41] Variance explained (Nagelkerke's R2*100): 0.53 sex, age at study enrollment, genetic PCs 1-20
PPM002710 PGS000907
(PRS_MDD)
PSS001303|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Muscle pain in Sertraline takers OR: 1.13 [0.97, 1.31] Variance explained (Nagelkerke's R2*100): 0.18 sex, age at study enrollment, genetic PCs 1-20
PPM002711 PGS000907
(PRS_MDD)
PSS001299|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Muscle pain in Escitalopram takers OR: 0.96 [0.8, 1.14] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002712 PGS000907
(PRS_MDD)
PSS001304|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Muscle pain in Venlafaxine takers OR: 1.22 [1.03, 1.45] Variance explained (Nagelkerke's R2*100): 0.51 sex, age at study enrollment, genetic PCs 1-20
PPM002713 PGS000907
(PRS_MDD)
PSS001295|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Muscle pain in Amitriptyline takers OR: 1.06 [0.8, 1.4] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002715 PGS000907
(PRS_MDD)
PSS001297|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Muscle pain in Desvenlafaxine takers OR: 1.0 [0.8, 1.24] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002716 PGS000907
(PRS_MDD)
PSS001296|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Muscle pain in Citalopram takers OR: 0.95 [0.72, 1.27] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002717 PGS000907
(PRS_MDD)
PSS001300|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Muscle pain in Fluoxetine takers OR: 1.3 [1.05, 1.6] Variance explained (Nagelkerke's R2*100): 0.77 sex, age at study enrollment, genetic PCs 1-20
PPM002718 PGS000907
(PRS_MDD)
PSS001298|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Muscle pain in Duloxetine takers OR: 0.99 [0.82, 1.2] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002720 PGS000907
(PRS_MDD)
PSS001263|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dry mouth in Sertraline takers OR: 1.04 [0.98, 1.11] Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20
PPM002721 PGS000907
(PRS_MDD)
PSS001259|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dry mouth in Escitalopram takers OR: 1.01 [0.94, 1.09] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002722 PGS000907
(PRS_MDD)
PSS001264|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dry mouth in Venlafaxine takers OR: 0.98 [0.91, 1.05] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002723 PGS000907
(PRS_MDD)
PSS001255|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dry mouth in Amitriptyline takers OR: 1.06 [0.95, 1.17] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002724 PGS000907
(PRS_MDD)
PSS001261|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dry mouth in Mirtazapine takers OR: 1.05 [0.94, 1.17] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002725 PGS000907
(PRS_MDD)
PSS001257|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dry mouth in Desvenlafaxine takers OR: 1.09 [0.99, 1.2] Variance explained (Nagelkerke's R2*100): 0.2 sex, age at study enrollment, genetic PCs 1-20
PPM002726 PGS000907
(PRS_MDD)
PSS001256|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dry mouth in Citalopram takers OR: 1.11 [1.0, 1.23] Variance explained (Nagelkerke's R2*100): 0.23 sex, age at study enrollment, genetic PCs 1-20
PPM002727 PGS000907
(PRS_MDD)
PSS001260|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dry mouth in Fluoxetine takers OR: 1.0 [0.92, 1.09] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002728 PGS000907
(PRS_MDD)
PSS001258|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dry mouth in Duloxetine takers OR: 1.03 [0.93, 1.13] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002729 PGS000907
(PRS_MDD)
PSS001262|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Dry mouth in Paroxetine takers OR: 0.98 [0.86, 1.1] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002730 PGS000907
(PRS_MDD)
PSS001403|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Sweating in Sertraline takers OR: 0.99 [0.92, 1.07] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002731 PGS000907
(PRS_MDD)
PSS001399|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Sweating in Escitalopram takers OR: 0.97 [0.89, 1.06] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002732 PGS000907
(PRS_MDD)
PSS001404|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Sweating in Venlafaxine takers OR: 1.04 [0.96, 1.12] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002733 PGS000907
(PRS_MDD)
PSS001395|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Sweating in Amitriptyline takers OR: 1.14 [0.96, 1.37] Variance explained (Nagelkerke's R2*100): 0.3 sex, age at study enrollment, genetic PCs 1-20
PPM002734 PGS000907
(PRS_MDD)
PSS001401|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Sweating in Mirtazapine takers OR: 1.05 [0.9, 1.22] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002735 PGS000907
(PRS_MDD)
PSS001397|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Sweating in Desvenlafaxine takers OR: 0.99 [0.9, 1.1] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002736 PGS000907
(PRS_MDD)
PSS001396|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Sweating in Citalopram takers OR: 1.14 [0.99, 1.3] Variance explained (Nagelkerke's R2*100): 0.29 sex, age at study enrollment, genetic PCs 1-20
PPM002737 PGS000907
(PRS_MDD)
PSS001400|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Sweating in Fluoxetine takers OR: 1.04 [0.94, 1.16] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002738 PGS000907
(PRS_MDD)
PSS001398|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Sweating in Duloxetine takers OR: 0.96 [0.86, 1.07] Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20
PPM002739 PGS000907
(PRS_MDD)
PSS001402|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Sweating in Paroxetine takers OR: 1.1 [0.94, 1.28] Variance explained (Nagelkerke's R2*100): 0.17 sex, age at study enrollment, genetic PCs 1-20
PPM002741 PGS000907
(PRS_MDD)
PSS001309|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Nausea in Escitalopram takers OR: 1.06 [0.98, 1.15] Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20
PPM002742 PGS000907
(PRS_MDD)
PSS001314|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Nausea in Venlafaxine takers OR: 1.08 [1.0, 1.17] Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20
PPM002743 PGS000907
(PRS_MDD)
PSS001305|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Nausea in Amitriptyline takers OR: 1.12 [0.95, 1.31] Variance explained (Nagelkerke's R2*100): 0.22 sex, age at study enrollment, genetic PCs 1-20
PPM002744 PGS000907
(PRS_MDD)
PSS001311|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Nausea in Mirtazapine takers OR: 1.08 [0.93, 1.25] Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20
PPM002745 PGS000907
(PRS_MDD)
PSS001307|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Nausea in Desvenlafaxine takers OR: 1.06 [0.96, 1.17] Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20
PPM002746 PGS000907
(PRS_MDD)
PSS001306|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Nausea in Citalopram takers OR: 1.11 [0.99, 1.25] Variance explained (Nagelkerke's R2*100): 0.24 sex, age at study enrollment, genetic PCs 1-20
PPM002747 PGS000907
(PRS_MDD)
PSS001310|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Nausea in Fluoxetine takers OR: 1.06 [0.97, 1.16] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002748 PGS000907
(PRS_MDD)
PSS001308|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Nausea in Duloxetine takers OR: 1.16 [1.04, 1.29] Variance explained (Nagelkerke's R2*100): 0.55 sex, age at study enrollment, genetic PCs 1-20
PPM002749 PGS000907
(PRS_MDD)
PSS001312|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Nausea in Paroxetine takers OR: 1.1 [0.96, 1.27] Variance explained (Nagelkerke's R2*100): 0.21 sex, age at study enrollment, genetic PCs 1-20
PPM002750 PGS000907
(PRS_MDD)
PSS001423|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Vomit in Sertraline takers OR: 1.21 [1.03, 1.43] Variance explained (Nagelkerke's R2*100): 0.44 sex, age at study enrollment, genetic PCs 1-20
PPM002751 PGS000907
(PRS_MDD)
PSS001419|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Vomit in Escitalopram takers OR: 0.96 [0.78, 1.18] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002752 PGS000907
(PRS_MDD)
PSS001424|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Vomit in Venlafaxine takers OR: 1.14 [0.96, 1.36] Variance explained (Nagelkerke's R2*100): 0.22 sex, age at study enrollment, genetic PCs 1-20
PPM002754 PGS000907
(PRS_MDD)
PSS001421|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Vomit in Mirtazapine takers OR: 1.23 [0.88, 1.72] Variance explained (Nagelkerke's R2*100): 0.45 sex, age at study enrollment, genetic PCs 1-20
PPM002755 PGS000907
(PRS_MDD)
PSS001417|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Vomit in Desvenlafaxine takers OR: 1.08 [0.86, 1.36] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002756 PGS000907
(PRS_MDD)
PSS001416|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Vomit in Citalopram takers OR: 1.19 [0.87, 1.64] Variance explained (Nagelkerke's R2*100): 0.32 sex, age at study enrollment, genetic PCs 1-20
PPM002757 PGS000907
(PRS_MDD)
PSS001420|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Vomit in Fluoxetine takers OR: 1.01 [0.8, 1.28] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002758 PGS000907
(PRS_MDD)
PSS001418|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Vomit in Duloxetine takers OR: 1.09 [0.87, 1.35] Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20
PPM002759 PGS000907
(PRS_MDD)
PSS001422|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Vomit in Paroxetine takers OR: 1.17 [0.86, 1.61] Variance explained (Nagelkerke's R2*100): 0.3 sex, age at study enrollment, genetic PCs 1-20
PPM002760 PGS000907
(PRS_MDD)
PSS001223|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Constipation in Sertraline takers OR: 1.15 [1.03, 1.29] Variance explained (Nagelkerke's R2*100): 0.29 sex, age at study enrollment, genetic PCs 1-20
PPM002761 PGS000907
(PRS_MDD)
PSS001219|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Constipation in Escitalopram takers OR: 1.16 [1.01, 1.33] Variance explained (Nagelkerke's R2*100): 0.32 sex, age at study enrollment, genetic PCs 1-20
PPM002762 PGS000907
(PRS_MDD)
PSS001224|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Constipation in Venlafaxine takers OR: 1.19 [1.07, 1.34] Variance explained (Nagelkerke's R2*100): 0.54 sex, age at study enrollment, genetic PCs 1-20
PPM002763 PGS000907
(PRS_MDD)
PSS001215|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Constipation in Amitriptyline takers OR: 1.16 [0.98, 1.37] Variance explained (Nagelkerke's R2*100): 0.38 sex, age at study enrollment, genetic PCs 1-20
PPM002764 PGS000907
(PRS_MDD)
PSS001221|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Constipation in Mirtazapine takers OR: 1.08 [0.89, 1.29] Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20
PPM002765 PGS000907
(PRS_MDD)
PSS001217|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Constipation in Desvenlafaxine takers OR: 1.03 [0.89, 1.2] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002767 PGS000907
(PRS_MDD)
PSS001220|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Constipation in Fluoxetine takers OR: 1.09 [0.94, 1.27] Variance explained (Nagelkerke's R2*100): 0.11 sex, age at study enrollment, genetic PCs 1-20
PPM002768 PGS000907
(PRS_MDD)
PSS001218|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Constipation in Duloxetine takers OR: 1.02 [0.89, 1.18] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002769 PGS000907
(PRS_MDD)
PSS001222|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Constipation in Paroxetine takers OR: 1.09 [0.9, 1.31] Variance explained (Nagelkerke's R2*100): 0.12 sex, age at study enrollment, genetic PCs 1-20
PPM002771 PGS000907
(PRS_MDD)
PSS001229|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Diarrhoea in Escitalopram takers OR: 1.01 [0.89, 1.16] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002772 PGS000907
(PRS_MDD)
PSS001234|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Diarrhoea in Venlafaxine takers OR: 1.13 [0.97, 1.32] Variance explained (Nagelkerke's R2*100): 0.2 sex, age at study enrollment, genetic PCs 1-20
PPM002773 PGS000907
(PRS_MDD)
PSS001225|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Diarrhoea in Amitriptyline takers OR: 1.02 [0.73, 1.42] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002774 PGS000907
(PRS_MDD)
PSS001231|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Diarrhoea in Mirtazapine takers OR: 1.13 [0.89, 1.42] Variance explained (Nagelkerke's R2*100): 0.18 sex, age at study enrollment, genetic PCs 1-20
PPM002775 PGS000907
(PRS_MDD)
PSS001227|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Diarrhoea in Desvenlafaxine takers OR: 1.01 [0.84, 1.21] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002776 PGS000907
(PRS_MDD)
PSS001226|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Diarrhoea in Citalopram takers OR: 0.95 [0.76, 1.19] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002777 PGS000907
(PRS_MDD)
PSS001230|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Diarrhoea in Fluoxetine takers OR: 0.99 [0.84, 1.17] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002778 PGS000907
(PRS_MDD)
PSS001228|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Diarrhoea in Duloxetine takers OR: 1.08 [0.9, 1.3] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002779 PGS000907
(PRS_MDD)
PSS001232|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Diarrhoea in Paroxetine takers OR: 1.47 [1.13, 1.91] Variance explained (Nagelkerke's R2*100): 1.92 sex, age at study enrollment, genetic PCs 1-20
PPM002780 PGS000907
(PRS_MDD)
PSS001253|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Drowsiness in Sertraline takers OR: 1.01 [0.94, 1.09] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002782 PGS000907
(PRS_MDD)
PSS001254|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Drowsiness in Venlafaxine takers OR: 1.0 [0.91, 1.1] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002783 PGS000907
(PRS_MDD)
PSS001245|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Drowsiness in Amitriptyline takers OR: 0.99 [0.89, 1.11] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002784 PGS000907
(PRS_MDD)
PSS001251|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Drowsiness in Mirtazapine takers OR: 1.06 [0.96, 1.18] Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20
PPM002785 PGS000907
(PRS_MDD)
PSS001247|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Drowsiness in Desvenlafaxine takers OR: 0.99 [0.88, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002786 PGS000907
(PRS_MDD)
PSS001246|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Drowsiness in Citalopram takers OR: 1.05 [0.93, 1.18] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002787 PGS000907
(PRS_MDD)
PSS001250|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Drowsiness in Fluoxetine takers OR: 1.04 [0.94, 1.14] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002788 PGS000907
(PRS_MDD)
PSS001248|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Drowsiness in Duloxetine takers OR: 0.96 [0.86, 1.08] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002789 PGS000907
(PRS_MDD)
PSS001252|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Drowsiness in Paroxetine takers OR: 0.97 [0.83, 1.12] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002790 PGS000907
(PRS_MDD)
PSS001413|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Trouble sleeping in Sertraline takers OR: 1.04 [0.97, 1.12] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002791 PGS000907
(PRS_MDD)
PSS001409|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Trouble sleeping in Escitalopram takers OR: 1.02 [0.94, 1.1] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002792 PGS000907
(PRS_MDD)
PSS001414|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Trouble sleeping in Venlafaxine takers OR: 1.02 [0.94, 1.1] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002793 PGS000907
(PRS_MDD)
PSS001405|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Trouble sleeping in Amitriptyline takers OR: 1.05 [0.88, 1.26] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002794 PGS000907
(PRS_MDD)
PSS001411|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Trouble sleeping in Mirtazapine takers OR: 1.13 [0.97, 1.32] Variance explained (Nagelkerke's R2*100): 0.27 sex, age at study enrollment, genetic PCs 1-20
PPM002795 PGS000907
(PRS_MDD)
PSS001407|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Trouble sleeping in Desvenlafaxine takers OR: 1.05 [0.95, 1.16] Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20
PPM002796 PGS000907
(PRS_MDD)
PSS001406|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Trouble sleeping in Citalopram takers OR: 1.0 [0.89, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002797 PGS000907
(PRS_MDD)
PSS001410|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Trouble sleeping in Fluoxetine takers OR: 1.05 [0.96, 1.15] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002798 PGS000907
(PRS_MDD)
PSS001408|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Trouble sleeping in Duloxetine takers OR: 0.97 [0.87, 1.09] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002800 PGS000907
(PRS_MDD)
PSS001203|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Anxiety in Sertraline takers OR: 1.13 [1.04, 1.22] Variance explained (Nagelkerke's R2*100): 0.29 sex, age at study enrollment, genetic PCs 1-20
PPM002801 PGS000907
(PRS_MDD)
PSS001199|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Anxiety in Escitalopram takers OR: 1.01 [0.91, 1.11] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002802 PGS000907
(PRS_MDD)
PSS001204|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Anxiety in Venlafaxine takers OR: 1.14 [1.04, 1.26] Variance explained (Nagelkerke's R2*100): 0.36 sex, age at study enrollment, genetic PCs 1-20
PPM002803 PGS000907
(PRS_MDD)
PSS001195|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Anxiety in Amitriptyline takers OR: 1.05 [0.87, 1.27] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002804 PGS000907
(PRS_MDD)
PSS001201|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Anxiety in Mirtazapine takers OR: 1.2 [1.03, 1.39] Variance explained (Nagelkerke's R2*100): 0.59 sex, age at study enrollment, genetic PCs 1-20
PPM002805 PGS000907
(PRS_MDD)
PSS001197|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Anxiety in Desvenlafaxine takers OR: 1.04 [0.92, 1.17] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002806 PGS000907
(PRS_MDD)
PSS001196|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Anxiety in Citalopram takers OR: 0.97 [0.85, 1.12] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002807 PGS000907
(PRS_MDD)
PSS001200|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Anxiety in Fluoxetine takers OR: 1.05 [0.96, 1.16] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002808 PGS000907
(PRS_MDD)
PSS001198|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Anxiety in Duloxetine takers OR: 1.0 [0.87, 1.14] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002809 PGS000907
(PRS_MDD)
PSS001202|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Anxiety in Paroxetine takers OR: 1.1 [0.94, 1.29] Variance explained (Nagelkerke's R2*100): 0.19 sex, age at study enrollment, genetic PCs 1-20
PPM002810 PGS000907
(PRS_MDD)
PSS001193|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Agitation in Sertraline takers OR: 1.04 [0.96, 1.13] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002811 PGS000907
(PRS_MDD)
PSS001189|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Agitation in Escitalopram takers OR: 1.06 [0.96, 1.17] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002812 PGS000907
(PRS_MDD)
PSS001194|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Agitation in Venlafaxine takers OR: 1.06 [0.97, 1.17] Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20
PPM002813 PGS000907
(PRS_MDD)
PSS001185|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Agitation in Amitriptyline takers OR: 1.02 [0.85, 1.23] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002814 PGS000907
(PRS_MDD)
PSS001191|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Agitation in Mirtazapine takers OR: 1.25 [1.08, 1.46] Variance explained (Nagelkerke's R2*100): 0.93 sex, age at study enrollment, genetic PCs 1-20
PPM002816 PGS000907
(PRS_MDD)
PSS001186|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Agitation in Citalopram takers OR: 1.05 [0.91, 1.21] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002817 PGS000907
(PRS_MDD)
PSS001190|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Agitation in Fluoxetine takers OR: 1.06 [0.96, 1.18] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002818 PGS000907
(PRS_MDD)
PSS001188|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Agitation in Duloxetine takers OR: 1.05 [0.91, 1.21] Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20
PPM002819 PGS000907
(PRS_MDD)
PSS001192|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Agitation in Paroxetine takers OR: 1.19 [1.02, 1.38] Variance explained (Nagelkerke's R2*100): 0.6 sex, age at study enrollment, genetic PCs 1-20
PPM002820 PGS000907
(PRS_MDD)
PSS001273|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Fatigue in Sertraline takers OR: 1.01 [0.94, 1.09] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002821 PGS000907
(PRS_MDD)
PSS001269|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Fatigue in Escitalopram takers OR: 0.96 [0.88, 1.05] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002822 PGS000907
(PRS_MDD)
PSS001274|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Fatigue in Venlafaxine takers OR: 1.06 [0.97, 1.16] Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20
PPM002823 PGS000907
(PRS_MDD)
PSS001265|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Fatigue in Amitriptyline takers OR: 1.12 [0.97, 1.28] Variance explained (Nagelkerke's R2*100): 0.25 sex, age at study enrollment, genetic PCs 1-20
PPM002824 PGS000907
(PRS_MDD)
PSS001271|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Fatigue in Mirtazapine takers OR: 1.06 [0.94, 1.2] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002826 PGS000907
(PRS_MDD)
PSS001266|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Fatigue in Citalopram takers OR: 0.98 [0.86, 1.11] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002827 PGS000907
(PRS_MDD)
PSS001270|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Fatigue in Fluoxetine takers OR: 1.02 [0.92, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002829 PGS000907
(PRS_MDD)
PSS001272|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Fatigue in Paroxetine takers OR: 0.96 [0.82, 1.11] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002831 PGS000907
(PRS_MDD)
PSS001429|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight gain in Escitalopram takers OR: 1.04 [0.97, 1.11] Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20
PPM002832 PGS000907
(PRS_MDD)
PSS001434|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight gain in Venlafaxine takers OR: 1.03 [0.96, 1.11] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002833 PGS000907
(PRS_MDD)
PSS001425|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight gain in Amitriptyline takers OR: 1.06 [0.95, 1.19] Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20
PPM002834 PGS000907
(PRS_MDD)
PSS001431|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight gain in Mirtazapine takers OR: 1.02 [0.93, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002835 PGS000907
(PRS_MDD)
PSS001427|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight gain in Desvenlafaxine takers OR: 1.11 [1.02, 1.22] Variance explained (Nagelkerke's R2*100): 0.33 sex, age at study enrollment, genetic PCs 1-20
PPM002836 PGS000907
(PRS_MDD)
PSS001426|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight gain in Citalopram takers OR: 1.14 [1.03, 1.25] Variance explained (Nagelkerke's R2*100): 0.4 sex, age at study enrollment, genetic PCs 1-20
PPM002837 PGS000907
(PRS_MDD)
PSS001430|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight gain in Fluoxetine takers OR: 1.04 [0.96, 1.12] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002838 PGS000907
(PRS_MDD)
PSS001428|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight gain in Duloxetine takers OR: 1.0 [0.91, 1.1] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002839 PGS000907
(PRS_MDD)
PSS001432|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight gain in Paroxetine takers OR: 1.11 [0.99, 1.24] Variance explained (Nagelkerke's R2*100): 0.28 sex, age at study enrollment, genetic PCs 1-20
PPM002840 PGS000907
(PRS_MDD)
PSS001443|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight loss in Sertraline takers OR: 0.9 [0.75, 1.07] Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20
PPM002841 PGS000907
(PRS_MDD)
PSS001439|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight loss in Escitalopram takers OR: 1.07 [0.88, 1.32] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002842 PGS000907
(PRS_MDD)
PSS001444|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight loss in Venlafaxine takers OR: 1.05 [0.84, 1.3] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002844 PGS000907
(PRS_MDD)
PSS001441|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight loss in Mirtazapine takers OR: 1.21 [0.85, 1.71] Variance explained (Nagelkerke's R2*100): 0.37 sex, age at study enrollment, genetic PCs 1-20
PPM002845 PGS000907
(PRS_MDD)
PSS001437|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight loss in Desvenlafaxine takers OR: 0.95 [0.74, 1.22] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002846 PGS000907
(PRS_MDD)
PSS001436|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight loss in Citalopram takers OR: 0.87 [0.61, 1.23] Variance explained (Nagelkerke's R2*100): 0.19 sex, age at study enrollment, genetic PCs 1-20
PPM002847 PGS000907
(PRS_MDD)
PSS001440|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight loss in Fluoxetine takers OR: 1.16 [0.96, 1.39] Variance explained (Nagelkerke's R2*100): 0.26 sex, age at study enrollment, genetic PCs 1-20
PPM002848 PGS000907
(PRS_MDD)
PSS001438|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight loss in Duloxetine takers OR: 0.96 [0.75, 1.23] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002849 PGS000907
(PRS_MDD)
PSS001442|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight loss in Paroxetine takers OR: 1.36 [0.88, 2.1] Variance explained (Nagelkerke's R2*100): 0.99 sex, age at study enrollment, genetic PCs 1-20
PPM002852 PGS000907
(PRS_MDD)
PSS001344|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Rashes in Venlafaxine takers OR: 1.0 [0.74, 1.36] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002853 PGS000907
(PRS_MDD)
PSS001335|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Rashes in Amitriptyline takers OR: 1.22 [0.73, 2.04] Variance explained (Nagelkerke's R2*100): 0.42 sex, age at study enrollment, genetic PCs 1-20
PPM002854 PGS000907
(PRS_MDD)
PSS001341|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Rashes in Mirtazapine takers OR: 1.0 [0.65, 1.52] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002855 PGS000907
(PRS_MDD)
PSS001337|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Rashes in Desvenlafaxine takers OR: 1.58 [1.13, 2.23] Variance explained (Nagelkerke's R2*100): 2.19 sex, age at study enrollment, genetic PCs 1-20
PPM002856 PGS000907
(PRS_MDD)
PSS001336|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Rashes in Citalopram takers OR: 1.1 [0.7, 1.74] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002857 PGS000907
(PRS_MDD)
PSS001340|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Rashes in Fluoxetine takers OR: 1.34 [0.91, 1.97] Variance explained (Nagelkerke's R2*100): 0.75 sex, age at study enrollment, genetic PCs 1-20
PPM002858 PGS000907
(PRS_MDD)
PSS001338|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Rashes in Duloxetine takers OR: 1.13 [0.75, 1.7] Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20
PPM002859 PGS000907
(PRS_MDD)
PSS001342|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Rashes in Paroxetine takers OR: 1.16 [0.69, 1.95] Variance explained (Nagelkerke's R2*100): 0.22 sex, age at study enrollment, genetic PCs 1-20
PPM002860 PGS000907
(PRS_MDD)
PSS001363|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Runny nose in Sertraline takers OR: 1.0 [0.79, 1.28] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002861 PGS000907
(PRS_MDD)
PSS001359|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Runny nose in Escitalopram takers OR: 0.91 [0.69, 1.19] Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20
PPM002862 PGS000907
(PRS_MDD)
PSS001364|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Runny nose in Venlafaxine takers OR: 1.06 [0.8, 1.42] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002863 PGS000907
(PRS_MDD)
PSS001355|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Runny nose in Amitriptyline takers OR: 0.59 [0.36, 0.98] Variance explained (Nagelkerke's R2*100): 2.43 sex, age at study enrollment, genetic PCs 1-20
PPM002864 PGS000907
(PRS_MDD)
PSS001361|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Runny nose in Mirtazapine takers OR: 0.85 [0.55, 1.3] Variance explained (Nagelkerke's R2*100): 0.25 sex, age at study enrollment, genetic PCs 1-20
PPM002865 PGS000907
(PRS_MDD)
PSS001357|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Runny nose in Desvenlafaxine takers OR: 0.8 [0.59, 1.07] Variance explained (Nagelkerke's R2*100): 0.58 sex, age at study enrollment, genetic PCs 1-20
PPM002868 PGS000907
(PRS_MDD)
PSS001358|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Runny nose in Duloxetine takers OR: 0.99 [0.71, 1.38] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002869 PGS000907
(PRS_MDD)
PSS001362|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Runny nose in Paroxetine takers OR: 0.9 [0.53, 1.52] Variance explained (Nagelkerke's R2*100): 0.11 sex, age at study enrollment, genetic PCs 1-20
PPM002870 PGS000907
(PRS_MDD)
PSS001353|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Reduced sexual desire in Sertraline takers OR: 1.0 [0.95, 1.06] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002871 PGS000907
(PRS_MDD)
PSS001349|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Reduced sexual desire in Escitalopram takers OR: 0.99 [0.93, 1.06] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002872 PGS000907
(PRS_MDD)
PSS001354|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Reduced sexual desire in Venlafaxine takers OR: 1.05 [0.99, 1.13] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002873 PGS000907
(PRS_MDD)
PSS001345|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Reduced sexual desire in Amitriptyline takers OR: 1.08 [0.96, 1.22] Variance explained (Nagelkerke's R2*100): 0.16 sex, age at study enrollment, genetic PCs 1-20
PPM002878 PGS000907
(PRS_MDD)
PSS001348|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Reduced sexual desire in Duloxetine takers OR: 0.99 [0.91, 1.09] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002879 PGS000907
(PRS_MDD)
PSS001352|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Reduced sexual desire in Paroxetine takers OR: 1.0 [0.9, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002883 PGS000907
(PRS_MDD)
PSS001205|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Blurry vision in Amitriptyline takers OR: 1.08 [0.86, 1.36] Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20
PPM002884 PGS000907
(PRS_MDD)
PSS001211|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Blurry vision in Mirtazapine takers OR: 1.05 [0.84, 1.31] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002885 PGS000907
(PRS_MDD)
PSS001207|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Blurry vision in Desvenlafaxine takers OR: 1.13 [0.94, 1.37] Variance explained (Nagelkerke's R2*100): 0.22 sex, age at study enrollment, genetic PCs 1-20
PPM002886 PGS000907
(PRS_MDD)
PSS001206|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Blurry vision in Citalopram takers OR: 1.39 [1.08, 1.79] Variance explained (Nagelkerke's R2*100): 1.2 sex, age at study enrollment, genetic PCs 1-20
PPM002887 PGS000907
(PRS_MDD)
PSS001210|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Blurry vision in Fluoxetine takers OR: 1.03 [0.85, 1.24] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002888 PGS000907
(PRS_MDD)
PSS001208|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Blurry vision in Duloxetine takers OR: 1.04 [0.87, 1.26] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002889 PGS000907
(PRS_MDD)
PSS001212|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Blurry vision in Paroxetine takers OR: 1.32 [1.0, 1.75] Variance explained (Nagelkerke's R2*100): 0.99 sex, age at study enrollment, genetic PCs 1-20
PPM002890 PGS000907
(PRS_MDD)
PSS001393|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide thoughts in Sertraline takers OR: 1.24 [1.14, 1.34] Variance explained (Nagelkerke's R2*100): 0.9 sex, age at study enrollment, genetic PCs 1-20
PPM002894 PGS000907
(PRS_MDD)
PSS001391|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide thoughts in Mirtazapine takers OR: 1.09 [0.94, 1.25] Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20
PPM002895 PGS000907
(PRS_MDD)
PSS001387|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide thoughts in Desvenlafaxine takers OR: 1.06 [0.94, 1.2] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002896 PGS000907
(PRS_MDD)
PSS001386|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide thoughts in Citalopram takers OR: 1.06 [0.92, 1.22] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002897 PGS000907
(PRS_MDD)
PSS001390|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide thoughts in Fluoxetine takers OR: 1.12 [1.02, 1.23] Variance explained (Nagelkerke's R2*100): 0.27 sex, age at study enrollment, genetic PCs 1-20
PPM002898 PGS000907
(PRS_MDD)
PSS001388|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide thoughts in Duloxetine takers OR: 0.98 [0.86, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002899 PGS000907
(PRS_MDD)
PSS001392|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide thoughts in Paroxetine takers OR: 1.22 [1.05, 1.42] Variance explained (Nagelkerke's R2*100): 0.8 sex, age at study enrollment, genetic PCs 1-20
PPM002900 PGS000907
(PRS_MDD)
PSS001383|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide attempt in Sertraline takers OR: 1.15 [1.01, 1.31] Variance explained (Nagelkerke's R2*100): 0.28 sex, age at study enrollment, genetic PCs 1-20
PPM002901 PGS000907
(PRS_MDD)
PSS001379|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide attempt in Escitalopram takers OR: 1.06 [0.9, 1.24] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002902 PGS000907
(PRS_MDD)
PSS001384|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide attempt in Venlafaxine takers OR: 1.36 [1.18, 1.58] Variance explained (Nagelkerke's R2*100): 1.35 sex, age at study enrollment, genetic PCs 1-20
PPM002903 PGS000907
(PRS_MDD)
PSS001375|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide attempt in Amitriptyline takers OR: 0.97 [0.75, 1.24] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002904 PGS000907
(PRS_MDD)
PSS001381|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide attempt in Mirtazapine takers OR: 1.11 [0.88, 1.4] Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20
PPM002905 PGS000907
(PRS_MDD)
PSS001377|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide attempt in Desvenlafaxine takers OR: 0.97 [0.78, 1.21] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002906 PGS000907
(PRS_MDD)
PSS001376|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide attempt in Citalopram takers OR: 0.96 [0.76, 1.21] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002907 PGS000907
(PRS_MDD)
PSS001380|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide attempt in Fluoxetine takers OR: 1.09 [0.95, 1.26] Variance explained (Nagelkerke's R2*100): 0.11 sex, age at study enrollment, genetic PCs 1-20
PPM002908 PGS000907
(PRS_MDD)
PSS001378|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide attempt in Duloxetine takers OR: 1.11 [0.89, 1.38] Variance explained (Nagelkerke's R2*100): 0.15 sex, age at study enrollment, genetic PCs 1-20
PPM002909 PGS000907
(PRS_MDD)
PSS001382|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide attempt in Paroxetine takers OR: 1.22 [0.95, 1.55] Variance explained (Nagelkerke's R2*100): 0.54 sex, age at study enrollment, genetic PCs 1-20
PPM002910 PGS000907
(PRS_MDD)
PSS001333|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Other side effects in Sertraline takers OR: 0.99 [0.91, 1.09] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002911 PGS000907
(PRS_MDD)
PSS001329|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Other side effects in Escitalopram takers OR: 0.96 [0.86, 1.07] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002912 PGS000907
(PRS_MDD)
PSS001334|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Other side effects in Venlafaxine takers OR: 1.14 [1.03, 1.27] Variance explained (Nagelkerke's R2*100): 0.31 sex, age at study enrollment, genetic PCs 1-20
PPM002913 PGS000907
(PRS_MDD)
PSS001325|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Other side effects in Amitriptyline takers OR: 1.07 [0.88, 1.29] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002914 PGS000907
(PRS_MDD)
PSS001331|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Other side effects in Mirtazapine takers OR: 1.03 [0.87, 1.2] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002915 PGS000907
(PRS_MDD)
PSS001327|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Other side effects in Desvenlafaxine takers OR: 1.02 [0.88, 1.18] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002916 PGS000907
(PRS_MDD)
PSS001326|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Other side effects in Citalopram takers OR: 0.95 [0.82, 1.1] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002917 PGS000907
(PRS_MDD)
PSS001330|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Other side effects in Fluoxetine takers OR: 1.05 [0.93, 1.18] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002918 PGS000907
(PRS_MDD)
PSS001328|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Other side effects in Duloxetine takers OR: 1.04 [0.89, 1.2] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002919 PGS000907
(PRS_MDD)
PSS001332|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Other side effects in Paroxetine takers OR: 0.97 [0.81, 1.16] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002920 PGS000907
(PRS_MDD)
PSS001323|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: No side effects in Sertraline takers OR: 1.04 [0.89, 1.21] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002921 PGS000907
(PRS_MDD)
PSS001319|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: No side effects in Escitalopram takers OR: 1.04 [0.89, 1.22] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002922 PGS000907
(PRS_MDD)
PSS001324|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: No side effects in Venlafaxine takers OR: 0.94 [0.79, 1.12] Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20
PPM002923 PGS000907
(PRS_MDD)
PSS001315|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: No side effects in Amitriptyline takers OR: 1.03 [0.84, 1.25] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002924 PGS000907
(PRS_MDD)
PSS001321|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: No side effects in Mirtazapine takers OR: 1.05 [0.83, 1.33] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002925 PGS000907
(PRS_MDD)
PSS001317|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: No side effects in Desvenlafaxine takers OR: 0.82 [0.68, 0.98] Variance explained (Nagelkerke's R2*100): 0.6 sex, age at study enrollment, genetic PCs 1-20
PPM002680 PGS000907
(PRS_MDD)
PSS001283|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Headaches in Sertraline takers OR: 1.03 [0.95, 1.11] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002683 PGS000907
(PRS_MDD)
PSS001275|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Headaches in Amitriptyline takers OR: 0.96 [0.81, 1.12] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002706 PGS000907
(PRS_MDD)
PSS001366|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Shakes in Citalopram takers OR: 1.16 [0.98, 1.38] Variance explained (Nagelkerke's R2*100): 0.32 sex, age at study enrollment, genetic PCs 1-20
PPM002714 PGS000907
(PRS_MDD)
PSS001301|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Muscle pain in Mirtazapine takers OR: 1.13 [0.9, 1.43] Variance explained (Nagelkerke's R2*100): 0.2 sex, age at study enrollment, genetic PCs 1-20
PPM002719 PGS000907
(PRS_MDD)
PSS001302|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Muscle pain in Paroxetine takers OR: 1.18 [0.87, 1.61] Variance explained (Nagelkerke's R2*100): 0.34 sex, age at study enrollment, genetic PCs 1-20
PPM002740 PGS000907
(PRS_MDD)
PSS001313|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Nausea in Sertraline takers OR: 1.08 [1.01, 1.15] Variance explained (Nagelkerke's R2*100): 0.13 sex, age at study enrollment, genetic PCs 1-20
PPM002753 PGS000907
(PRS_MDD)
PSS001415|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Vomit in Amitriptyline takers OR: 0.93 [0.65, 1.33] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002766 PGS000907
(PRS_MDD)
PSS001216|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Constipation in Citalopram takers OR: 1.02 [0.85, 1.22] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002770 PGS000907
(PRS_MDD)
PSS001233|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Diarrhoea in Sertraline takers OR: 1.05 [0.94, 1.16] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002781 PGS000907
(PRS_MDD)
PSS001249|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Drowsiness in Escitalopram takers OR: 0.96 [0.89, 1.05] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002799 PGS000907
(PRS_MDD)
PSS001412|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Trouble sleeping in Paroxetine takers OR: 1.06 [0.92, 1.22] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002815 PGS000907
(PRS_MDD)
PSS001187|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Agitation in Desvenlafaxine takers OR: 1.07 [0.94, 1.21] Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20
PPM002825 PGS000907
(PRS_MDD)
PSS001267|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Fatigue in Desvenlafaxine takers OR: 1.02 [0.91, 1.15] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002828 PGS000907
(PRS_MDD)
PSS001268|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Fatigue in Duloxetine takers OR: 0.93 [0.83, 1.04] Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20
PPM002830 PGS000907
(PRS_MDD)
PSS001433|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight gain in Sertraline takers OR: 1.02 [0.96, 1.08] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002843 PGS000907
(PRS_MDD)
PSS001435|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Weight loss in Amitriptyline takers OR: 1.09 [0.67, 1.78] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002850 PGS000907
(PRS_MDD)
PSS001343|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Rashes in Sertraline takers OR: 1.04 [0.8, 1.36] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002851 PGS000907
(PRS_MDD)
PSS001339|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Rashes in Escitalopram takers OR: 1.09 [0.79, 1.5] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002866 PGS000907
(PRS_MDD)
PSS001356|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Runny nose in Citalopram takers OR: 1.05 [0.73, 1.51] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002867 PGS000907
(PRS_MDD)
PSS001360|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Runny nose in Fluoxetine takers OR: 1.03 [0.76, 1.4] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002874 PGS000907
(PRS_MDD)
PSS001351|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Reduced sexual desire in Mirtazapine takers OR: 0.99 [0.9, 1.1] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002875 PGS000907
(PRS_MDD)
PSS001347|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Reduced sexual desire in Desvenlafaxine takers OR: 1.11 [1.02, 1.21] Variance explained (Nagelkerke's R2*100): 0.34 sex, age at study enrollment, genetic PCs 1-20
PPM002876 PGS000907
(PRS_MDD)
PSS001346|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Reduced sexual desire in Citalopram takers OR: 1.1 [1.01, 1.2] Variance explained (Nagelkerke's R2*100): 0.28 sex, age at study enrollment, genetic PCs 1-20
PPM002877 PGS000907
(PRS_MDD)
PSS001350|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Reduced sexual desire in Fluoxetine takers OR: 1.05 [0.98, 1.12] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002880 PGS000907
(PRS_MDD)
PSS001213|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Blurry vision in Sertraline takers OR: 0.96 [0.83, 1.11] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002881 PGS000907
(PRS_MDD)
PSS001209|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Blurry vision in Escitalopram takers OR: 1.03 [0.87, 1.22] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002882 PGS000907
(PRS_MDD)
PSS001214|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Blurry vision in Venlafaxine takers OR: 0.97 [0.84, 1.12] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002891 PGS000907
(PRS_MDD)
PSS001389|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide thoughts in Escitalopram takers OR: 1.09 [0.99, 1.2] Variance explained (Nagelkerke's R2*100): 0.15 sex, age at study enrollment, genetic PCs 1-20
PPM002892 PGS000907
(PRS_MDD)
PSS001394|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide thoughts in Venlafaxine takers OR: 1.19 [1.09, 1.31] Variance explained (Nagelkerke's R2*100): 0.63 sex, age at study enrollment, genetic PCs 1-20
PPM002893 PGS000907
(PRS_MDD)
PSS001385|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: Suicide thoughts in Amitriptyline takers OR: 0.94 [0.8, 1.11] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002926 PGS000907
(PRS_MDD)
PSS001316|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: No side effects in Citalopram takers OR: 1.08 [0.92, 1.28] Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20
PPM002927 PGS000907
(PRS_MDD)
PSS001320|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: No side effects in Fluoxetine takers OR: 1.05 [0.91, 1.21] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002928 PGS000907
(PRS_MDD)
PSS001318|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: No side effects in Duloxetine takers OR: 0.91 [0.74, 1.13] Variance explained (Nagelkerke's R2*100): 0.12 sex, age at study enrollment, genetic PCs 1-20
PPM002929 PGS000907
(PRS_MDD)
PSS001322|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. medRxiv (2021)
|Pre
Reported Trait: No side effects in Paroxetine takers OR: 0.97 [0.77, 1.22] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM015246 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (rule breaking) partial R²: 0.00268 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015300 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (Cognitive total) partial R²: 0.00106 age, PCs1-3
PPM015241 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (withdrawn) partial R²: 0.00533 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015242 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (somatic symptoms) partial R²: 0.00626 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015243 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (social problems) partial R²: 0.00358 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015244 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (thought problems) partial R²: 0.00276 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015247 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (aggressive behaviour) partial R²: 0.00203 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015248 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (internalising) partial R²: 0.00815 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015249 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (externalising) partial R²: 0.00246 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015250 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (total problems) partial R²: 0.00528 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015251 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Dsm5 depression) partial R²: 0.00752 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015252 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Dsm5 anxety disorder) partial R²: 0.00657 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015253 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Dsm5 somatic problem) partial R²: 0.00516 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015254 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Dsm5 adhd) partial R²: 0.00088 age, PCs1-3
PPM015255 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Dsm5 opppsit) partial R²: 0.00172 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015256 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Dsm5 conduct) partial R²: 0.00205 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015257 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Sluggish cognitive tempo) partial R²: 0.0067 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015258 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Obsessive compulsive disorder) partial R²: 0.00297 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015259 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (stress) partial R²: 0.00464 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015260 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (Picture vocabulary) partial R²: 0.00077 age, PCs1-3
PPM015261 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (Flanker test) partial R²: 7e-05 age, PCs1-3
PPM015262 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (list sorting) partial R²: 0.00112 age, PCs1-3
PPM015263 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (card sorting) partial R²: 0.00064 age, PCs1-3
PPM015264 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (pattern comparison) partial R²: 0.00012 age, PCs1-3
PPM015265 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (Picture sequence) partial R²: 0.00045 age, PCs1-3
PPM015266 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (reading) partial R²: 0.00281 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015267 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (fluid composite) partial R²: 0.00047 age, PCs1-3
PPM015268 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (Crystallized composite) partial R²: 0.00222 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015269 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (Cognitive total) partial R²: 0.00155 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015270 PGS002789
(MDD_SDPR)
PSS009953|
European Ancestry|
68,614 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (fluid composite) partial R²: 0.00137 age, PCs1-10 the observed partial R² were higher than random R²s
PPM015271 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (anxious/depressed) partial R²: 0.00213 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015272 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (withdrawn) partial R²: 0.00201 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015273 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (somatic symptoms) partial R²: 0.00469 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015274 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (social problems) partial R²: 0.00414 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015275 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (thought problems) partial R²: 0.00322 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015276 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (attention problems) partial R²: 0.00218 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015277 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (rule breaking) partial R²: 0.00165 age, PCs1-3
PPM015279 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (internalising) partial R²: 0.00397 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015280 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (externalising) partial R²: 0.00439 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015281 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (total problems) partial R²: 0.00566 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015282 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Dsm5 depression) partial R²: 0.00515 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015283 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Dsm5 anxety disorder) partial R²: 0.00335 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015284 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Dsm5 somatic problem) partial R²: 0.00266 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015285 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Dsm5 adhd) partial R²: 0.00154 age, PCs1-3
PPM015286 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Dsm5 opppsit) partial R²: 0.00642 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015287 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Dsm5 conduct) partial R²: 0.00155 age, PCs1-3
PPM015288 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Sluggish cognitive tempo) partial R²: 0.00254 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015289 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (Obsessive compulsive disorder) partial R²: 0.00049 age, PCs1-3
PPM015290 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (stress) partial R²: 0.0055 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015291 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (Picture vocabulary) partial R²: 0.00143 age, PCs1-3
PPM015292 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (Flanker test) partial R²: 0.00019 age, PCs1-3
PPM015293 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (list sorting) partial R²: 0.00068 age, PCs1-3
PPM015294 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (card sorting) partial R²: 6e-05 age, PCs1-3
PPM015295 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (pattern comparison) partial R²: 5e-05 age, PCs1-3
PPM015296 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (Picture sequence) partial R²: 0.00048 age, PCs1-3
PPM015297 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (reading) partial R²: 0.00014 age, PCs1-3
PPM015301 PGS002789
(MDD_SDPR)
PSS009951|
European Ancestry|
78,561 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (fluid composite) partial R²: 0.00137 age, PCs1-10 the observed partial R² were higher than random R²s
PPM015422 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Genu of corpus callosum partial R²: 0.00139 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015423 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Body of corpus callosum partial R²: 0.00095 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015424 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Anterior limb of internal capsule R partial R²: 0.00161 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015425 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Anterior limb of internal capsule L partial R²: 0.00093 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015426 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Posterior limb of internal capsule R partial R²: 0.0008 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015427 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Anterior corona radiata R partial R²: 0.00087 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015428 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Anterior corona radiata L partial R²: 0.00092 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015429 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cingulum cingulate gyrus R partial R²: 0.00105 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015430 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Superior frontooccipital fasciculus R partial R²: 0.00096 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015431 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Genu of corpus callosum partial R²: 0.00106 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015432 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Body of corpus callosum partial R²: 0.00123 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015433 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Anterior limb of internal capsule R partial R²: 0.00155 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015434 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Anterior corona radiata R partial R²: 0.00097 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015435 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Anterior corona radiata L partial R²: 0.00097 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015436 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Superior corona radiata R partial R²: 0.00146 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015437 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Superior corona radiata L partial R²: 0.00099 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015438 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Superior longitudinal fasciculus R partial R²: 0.00094 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015439 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Superior longitudinal fasciculus L partial R²: 0.00109 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015440 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Superior frontooccipital fasciculus R partial R²: 0.00081 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015441 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Anterior thalamic radiation right partial R²: 0.00102 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015442 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Forceps minor partial R²: 0.00115 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015443 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Superior longitudinal fasciculus L partial R²: 0.00099 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015444 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Superior thalamic radiation R partial R²: 0.00131 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015445 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: ICA component_83 partial R²: 0.00079 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015446 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: ICA component_104 partial R²: 0.00119 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015447 PGS002789
(MDD_SDPR)
PSS009952|
European Ancestry|
10,343 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: ICA component_202 partial R²: 0.00058 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015240 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (anxious/depressed) partial R²: 0.00486 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015245 PGS002789
(MDD_SDPR)
PSS009950|
European Ancestry|
2,524 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (attention problems) partial R²: 0.00211 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015278 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Psychiatric behavior (aggressive behaviour) partial R²: 0.00498 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015298 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (fluid composite) partial R²: 0.00067 age, PCs1-3
PPM015299 PGS002789
(MDD_SDPR)
PSS009949|
European Ancestry|
2,198 individuals
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Reported Trait: Cognitive function (Crystallized composite) partial R²: 0.00088 age, PCs1-3

Evaluated Samples

PGS Sample Set ID
(PSS)
Phenotype Definitions and Methods Participant Follow-up Time Sample Numbers Age of Study Participants Sample Ancestry Additional Ancestry Description Cohort(s) Additional Sample/Cohort Information
PSS009949 NIH Toolbox was used to measure cognition in ABCD. Children’s problems and competencies were rated using the parent-reported Children Behavior Checklist (CBCL). Details of the ABCD MRI data acquisition and analysis have been published previously. 2,198 individuals,
0.0 % Male samples
Mean = 9.89 years
Sd = 0.61 years
European ABCD
PSS000294 Participants completed an online follow-up questionnaire assessing common mental health disorders, including MDD symptoms. Phenotypes were derived from this questionnaire. Individuals with probable MDD met lifetime criteria based on their responses to questions derived from the Composite International Diagnostic Interview. We excluded cases if they self-reported diagnoses of schizophrenia, other psychoses, or bipolar disorder. Controls were excluded if they self-reported any mental illness, taking any drug with an antidepressant indication, or had been hospitalised with a mood disorder or met previously-defined criteria for a mood disorder.
[
  • 29,475 cases
  • , 63,482 controls
]
,
45.0 % Male samples
Range = [46.0, 80.0] years European UKB
PSS001185
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001186
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001187
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001188
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001189
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001190
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001191
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001192
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001193
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001194
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001195
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001196
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001197
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001198
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001199
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001200
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001201
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001202
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001203
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001204
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001205
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001206
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001207
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001208
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001209
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001210
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001211
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001212
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001213
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001214
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001215
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001216
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001217
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001218
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001219
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001220
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001221
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001222
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001223
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001224
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001225
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001226
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001227
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001228
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001229
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001230
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001231
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001232
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001233
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001234
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001235
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001236
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001237
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001238
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001239
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001240
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001241
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001242
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001243
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001244
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001245
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001246
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001247
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001248
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001249
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001250
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001251
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001252
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001253
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001254
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001255
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001256
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001257
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001258
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001259
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001260
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001261
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001262
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001263
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001264
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001265
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001266
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001267
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001268
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001269
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001270
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001271
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001272
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001273
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001274
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001275
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001276
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001277
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001278
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001279
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001280
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001281
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001282
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001283
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001284
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS009950 NIH Toolbox was used to measure cognition in ABCD. Children’s problems and competencies were rated using the parent-reported Children Behavior Checklist (CBCL). Details of the ABCD MRI data acquisition and analysis have been published previously. 2,524 individuals,
100.0 % Male samples
Mean = 9.92 years
Sd = 0.62 years
European ABCD
PSS009951 Fluid intelligence test 78,561 individuals,
0.0 % Male samples
Mean = 57.46 years
Sd = 8.08 years
European UKB
PSS009952 imaging-derived phenotypes (IDPs) generated by an image-processing pipeline developed and ran on behalf of the UKB 10,343 individuals,
0.0 % Male samples
Mean = 63.13 years
Sd = 7.3 years
European UKB
PSS009953 Fluid intelligence test 68,614 individuals,
100.0 % Male samples
Mean = 58.39 years
Sd = 8.36 years
European UKB
PSS001295
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001296
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001297
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001298
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001299
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001300
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001301
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001302
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001303
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001304
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001305
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001306
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001307
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001308
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001309
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001310
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001311
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001312
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001313
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001314
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001315
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001316
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001317
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001318
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001319
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001320
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS000250
[
  • 14,696 cases
  • , 22,013 controls
]
European 15 cohorts
  • BOMA
  • ,CoLaus
  • ,Edinburgh
  • ,GenPOD
  • ,GenRED
  • ,MARS
  • ,MPIP
  • ,NESDA
  • ,QIMR
  • ,RADIANT
  • ,RS
  • ,SHIP
  • ,STAR*D
  • ,TwinGene
  • ,i2b2
Part of PGC29 (PMID: 29700475)
PSS001321
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001323
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001324
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001325
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001326
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001327
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001328
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001329
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001330
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001331
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001332
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001333
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001334
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001335
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001336
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001337
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001338
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001339
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001340
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001341
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001342
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001343
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001344
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001345
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001346
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001347
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001348
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001349
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001350
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001351
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001352
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001353
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001354
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001355
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001356
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001357
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001358
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001359
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001360
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001361
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001362
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001363
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001364
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001365
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001366
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001367
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001368
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001369
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001370
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001371
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001372
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001373
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001374
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001375
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001376
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001377
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001378
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001379
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001380
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001381
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001382
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001383
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001384
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001385
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001386
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001387
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001388
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001389
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001390
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001391
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001392
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001393
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001394
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001395
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001396
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001397
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001398
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001399
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001400
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001401
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001402
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001403
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001404
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001405
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001406
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001407
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001408
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001409
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001410
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001411
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001412
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001413
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001414
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001415
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001416
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001417
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001418
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001419
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001420
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001421
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001422
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001423
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001424
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001425
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001426
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001427
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001428
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001429
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001430
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001431
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001432
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001433
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001434
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001435
[
  • 140 cases
  • , 1,517 controls
]
European AGDS
PSS001436
[
  • 367 cases
  • , 2,218 controls
]
European AGDS
PSS001437
[
  • 489 cases
  • , 2,035 controls
]
European AGDS
PSS001438
[
  • 382 cases
  • , 1,613 controls
]
European AGDS
PSS001439
[
  • 712 cases
  • , 3,653 controls
]
European AGDS
PSS001440
[
  • 583 cases
  • , 3,087 controls
]
European AGDS
PSS001441
[
  • 186 cases
  • , 1,801 controls
]
European AGDS
PSS001442
[
  • 236 cases
  • , 1,344 controls
]
European AGDS
PSS001443
[
  • 1,020 cases
  • , 4,699 controls
]
European AGDS
PSS001444
[
  • 794 cases
  • , 3,173 controls
]
European AGDS
PSS001322
[
  • 236 cases
  • , 1,344 controls
]
European AGDS